PTEN and prostate cancer: We previously analyzed phosphoinositide acyl variants in prostate cancer tissues from 16 surgical patients using reverse-phase chromatography-tandem mass spectrometry; however, we did not find a similar acyl chain distortion as in Pten-deficient mouse samples.